Case studies
Our success is defined by our culture and shared ambition to create a positive impact, here you can find our caser studies which really showcase the best of our Commitment and our Purpose.
Bringing anti-ageing benefits to make-up
Developed through one of our Smart Partnerships, Majestem® Drypure™ from our beauty actives business, Sederma, brings anti-ageing and environmental protection benefits to make-up.
Collaboration to deliver new vaccine adjuvants
In 2021 we established a strategic collaboration with the Danish government’s life science research institute, Statens Serum Institute (SSI).
Focusing on D&I in Asia
Colleagues in Asia have been leading a programme of raising awareness, building an inclusive culture, and driving inclusivity in recruitment.
Investing in organic expansion in Agriculture
Atlox 4913TM is valued by customers for creating stable dispersions in complex crop formulations, ensuring consistent distribution of actives and preventing formulation breakdown.
Human Performance programme
Our behavioural safety improvement programmes were standardised into a Group-wide Behavioural Safety Observation programme, implemented across all manufacturing sites since 2015.
Leveraging expertise in UV filters for Asian markets
There are over three million cases of skin cancer globally each year, responsible for tens of thousands of deaths. Our range of sunscreens meets a clear need and is an important pillar of our...
Leveraging Group-wide capabilities to accelerate the development of natural active ingredients
The move in cosmetics towards replacing synthetic ingredients with sustainable alternatives is increasing demand for naturally sourced actives.
Improving the customer experience in China
Our .CN website transformation, which was launched in 2020, has created an entirely new online experience for customers in fast-growing Chinese markets.
Investing in mRNA and gene therapy
As the core of our lipid systems capability within the Health Care business, Avanti is primarily focused on developing innovative lipid-based products of unparalleled purity to address specific...
Net zero roadmap for UK manufacturing site
We became one of the first UK manufacturing sites to develop a 2050 net zero roadmap as part of the UK Government’s Department for Business, Energy and Industrial Strategy ‘Industry of the Future’...
Transition to bio-based MPG
Transitioning our raw materials to bio-based sources will enable us to make a significant positive impact.
New frontiers in fragrance and flavours
Croda acquired international fragrances and flavours company Iberchem in 2020, the largest acquisition in our history and a major move into a market strongly aligned with our business.
Uni of Cambridge case study
Working with technology designers NiTech Solutions and The University of Cambridge’s Institute for Manufacturing, we created a new process to manufacture more sustainable surfactants. Traditionally,...
Croda supports Pfizer-BioNTech COVID-19 vaccine
Avanti, a company we acquired in 2020, has a strong track record in supplying R&D quantities of lipid-based drug delivery technologies to pharmaceutical companies including those developing mRNA drugs...
Waste management
Iberchem, our global fragrance and flavours business based in Spain, has championed waste management best practices through robust policies and employee education programmes.
Reforestation
Revitalising ecosystems, improving biodiversity and creating social and economic benefits for local communities.
Responsible business
/Images/Corporate/Corporate V2/Sustainability/Our commitment sustainability image
1.5°C science-based target validation
In July 2021 we became only the third major chemical company globally to have a 1.5ºC science-based target validated.
Supplying delivery systems to help prevent cardiovascular disease
Nucleic acid-based therapies are the next big blockbuster drug class opening up exciting applications such as gene editing, where a patient’s genetic material can be modified to correct a disorder.